title: Pure red cell aplasia in a patient of chronic granulocyte leukemia associated with imatinib.
authors.forename: Hai-tao
authors.initials: HT
authors.lastname: Meng
authors.forename: Ying
authors.initials: Y
authors.lastname: Li
authors.forename: Jie
authors.initials: J
authors.lastname: Jin
authors.forename: Wen-bin
authors.initials: WB
authors.lastname: Qian
authors.forename: Chun-mei
authors.initials: CM
authors.lastname: Yang
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001549:Benzamides; D001772:Blood Cell Count; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D012010:Red-Cell Aplasia, Pure / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate